XLON
NANO
Market cap6mUSD
Oct 07, Last price
2.79GBP
1D
4.10%
1Q
11.60%
Jan 2017
-93.80%
IPO
-94.51%
Name
Nanoco Group PLC
Chart & performance
P/E
—
P/S
0.67
EPS
—
Div yield, %
—
Shrs. gr., 5y
-6.03%
Rev. gr., 5y
14.59%
Revenues
8m
-3.25%
Net income
-2m
L+75.34%
CFO
-5m
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nanoco Group plc, along with its subsidiaries, specializes in the innovation, production, and commercialization of advanced nanoscale materials tailored for a diverse range of commercial sectors. Its product portfolio features CFQD quantum dots, which are fluorescent semiconductor nanoparticles utilized for applications such as OLED and µLED color conversion, quantum dot electroluminescence (QD-EL), and security tagging. Further offerings include HEATWAVE quantum dots, designed for the sensor industry, and VIVODOTS nanoparticles, specifically engineered for medical and veterinary applications. The company maintains a significant international footprint, with operations extending across the United Kingdom, Japan, Singapore, Holland, France, Taiwan, Canada, Saudi Arabia, and the United States. Established in 2001, Nanoco Group plc is headquartered in Runcorn, UK, having previously traded as Evolutec Group plc before rebranding to its current name in April 2009.
Related entities
Subsidiaries
NANOCO TECHNOLOGIES LIMITED
Key people
Non-Executive Chairman of the Board · since 2016
Nigel Pickett
Chief Technology Officer, Executive Director
Michael Edelman
Chief Executive Officer, Executive Director
Senior Independent Non-Executive Director · since 2019
Gordon James Hall
Non-Executive Independent Director · since 2015
IPO date
May 01, 2009
Employees
36
Domiciled in
GB
Incorporated in
GB
Headquarters & legal address
SCIENCE CENTRE
THE HEATH BUSINESS AND TECHNICAL PARK
RUNCORN, CHW WA7 4QX
GB
THE HEATH BUSINESS AND TECHNICAL PARK
RUNCORN, CHW WA7 4QX
GB
Previous name
EVOLUTEC GROUP PLC
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑07 | 2024‑07 | 2023‑07 | 2022‑07 | 2021‑07 | 2020‑07 | 2019‑07 | 2018‑07 | 2017‑07 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||